Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 5/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | BCHE | P06276 | 1/20 | 0.38 |
| ▸ | CES1 | P23141 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | HTR2C | P28335 | 2/20 | 0.32 |
| ▸ | KDM1A | O60341 | 2/20 | 0.32 |
| ▸ | KDM1B | Q8NB78 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | NR2F2 | P24468 | 1/20 | 0.32 |
| ▸ | NOD2 | Q9HC29 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | NQO2 | P16083 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29366549 | 1.00 | TSHR (0.47) | TSHRCYP3A4MAPK1ALDH1A1BCHE | |
| SCHEMBL120851 | 0.93 | ALDH1A1 (0.42) | TSHRCYP3A4MAPK1ALDH1A1BCHE | |
| SCHEMBL482796 | 0.89 | TSHR (0.42) | TSHRCYP3A4MAPK1ALDH1A1BCHE | |
| SCHEMBL11045804 | 0.86 | ALDH1A1 (0.38) | TSHRCYP3A4MAPK1ALDH1A1BCHE | |
| SCHEMBL29637482 | 0.85 | TSHR (0.44) | TSHRCYP3A4MAPK1ALDH1A1BCHE | |
| SCHEMBL1135594 | 0.85 | TSHR (0.44) | TSHRCYP3A4MAPK1ALDH1A1BCHE | |
| SCHEMBL19831167 | 0.80 | BCHE (0.45) | TSHRCYP3A4MAPK1ALDH1A1BCHE | |
| SCHEMBL14866666 | 0.80 | BCHE (0.45) | TSHRCYP3A4MAPK1ALDH1A1BCHE | |
| SCHEMBL272760 | 0.78 | CYP3A4 (0.63) | TSHRCYP3A4MAPK1ALDH1A1BCHE | |
| SCHEMBL31387618 | 0.78 | CYP3A4 (0.63) | TSHRCYP3A4MAPK1ALDH1A1BCHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 189 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115490658-B | Preparation method of 4,4' -oxydiphthalic anhydride | 天津众泰材料科技有限公司 | 2023-11-14 | — | — | CN | claimed |
| CN-115490658-A | Preparation method of 4,4' -oxydiphthalic anhydride | 天津众泰材料科技有限公司 | 2022-12-20 | — | — | CN | claimed |
| US-12479849-B2 | EGFR inhibitors for the treatment of cancer | HOFFMANN-LA ROCHE INC. (US) | 2025-11-25 | — | — | US | disclosed |
| EP-4065566-B1 | TRPM8 MODULATORS | GIVAUDAN SA (CH) | 2025-01-01 | — | — | EP | disclosed |
| EP-4426679-A1 | SPIRO-(INDANE-FLUORENE) TYPE COMPOUNDS AND THEIR USE IN ORGANIC ELECTRONICS | DOTTIKON ES HOLDING AG (CH) | 2024-09-11 | — | — | EP | disclosed |
| CN-118251380-A | Spiro- (indan-fluorene) compounds and their use in organic electronic devices | 多蒂肯独家合成控股公司 | 2024-06-25 | — | — | CN | disclosed |
| US-11917912-B2 | Organic compound, organic light-emitting element, display apparatus, photoelectric conversion apparatus, electronic apparatus, illumination apparatus, moving object, and exposure light source | CANON KABUSHIKI KAISHA (JP) | 2024-02-27 | — | — | US | disclosed |
| CN-117466745-A | Method for synthesizing arylamine compound by using photochemical manganese as catalyst | 陕西师范大学 | 2024-01-30 | — | — | CN | disclosed |
| CN-115490658-B | Preparation method of 4,4' -oxydiphthalic anhydride | 天津众泰材料科技有限公司 | 2023-11-14 | — | — | CN | disclosed |
| WO-2023078824-A1 | SPIRO-(INDANE-FLUORENE) TYPE COMPOUNDS AND THEIR USE IN ORGANIC ELECTRONICS | DOTTIKON ES HOLDING AG (CH) | 2023-05-11 | — | — | WO | disclosed |
| EP-3986896-B1 | EGFR INHIBITORS FOR THE TREATMENT OF CANCER | HOFFMANN LA ROCHE (CH) | 2023-03-15 | — | — | EP | disclosed |
| EP-0537223-A1 | NEW 6-ARYL-6H-DIBENZO-[c,e][1,2]-OXAPHOSPHORINES, A METHOD FOR PREPARING THEM, AND THEIR USE FOR THE STABILIZATION OF PLASTICS, IN PARTICULAR POLYOLEFIN MOULDING MATERIALS. | HOECHST AG (DE) | 1993-04-21 | — | — | EP | disclosed |
| EP-0489050-A1 | ARYL ESTER AMIDE HALIDES OF PHOSPHONOUS ACID, ARYL ESTER AMIDES OF PHOSPHONOUS ACID, PROCESS FOR PREPARING THEM AND THEIR USE TO STABILIZE PLASTICS | HOECHST AKTIENGESELLSCHAFT (DE) | 1992-06-10 | — | — | EP | disclosed |
| EP-0472564-A1 | ARYLESTERS OF PHOSPHONOUS ACID, PROCESS FOR PREPARING THEM AND THEIR USE TO STABILIZE PLASTICS, IN PARTICULAR POLYOLEFIN MOULDING MATERIALS. | HOECHST AG (DE) | 1992-03-04 | — | — | EP | disclosed |
| WO-1992000306-A1 | NEW 6-ARYL-6H-DIBENZO-[c,e][1,2]-OXAPHOSPHORINES, A METHOD FOR PREPARING THEM, AND THEIR USE FOR THE STABILIZATION OF PLASTICS, IN PARTICULAR POLYOLEFIN MOULDING MATERIALS | HOECHST AKTIENGESELLSHAFT (DE) | 1992-01-09 | — | — | WO | disclosed |
| WO-1992000304-A1 | NEW PHOSPHONIC ACID ARYL ESTER HALIDES AND A METHOD FOR PREPARING THEM | HOECHST AKTIENGESELLSCHAFT (DE) | 1992-01-09 | — | — | WO | disclosed |
| WO-1991002738-A1 | ARYL ESTER AMIDE HALIDES OF PHOSPHONOUS ACID, ARYL ESTER AMIDES OF PHOSPHONOUS ACID, PROCESS FOR PREPARING THEM AND THEIR USE TO STABILIZE PLASTICS | HOECHST AKTIENGESELLSCHAFT (DE) | 1991-03-07 | — | — | WO | disclosed |
| WO-1990014349-A2 | ARYLESTERS OF PHOSPHONOUS ACID, PROCESS FOR PREPARING THEM AND THEIR USE TO STABILIZE PLASTICS, IN PARTICULAR POLYOLEFIN MOULDING MATERIALS | HOECHST AKTIENGESELLSCHAFT (DE) | 1990-11-29 | — | — | WO | disclosed |
| US-4330473-A | FLUORAN COLOR-FORMER | YAMAMOTO KAGAKU GOSEI KABUSHIKI KAISHA (JP) | 1982-05-18 | — | — | US | disclosed |
| US-3960538-A | INHIBITION OF ALGAE | MILLMASTER ONYX CORPORATION (US) | 1976-06-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11917912-B2 | Organic compound, organic light-emitting element, display apparatus, photoelectric conversion apparatus, electronic apparatus, illumination apparatus, moving object, and exposure light source | AOX1, SOD1, L1CAM | TSHR 1720/4885CYP3A4 611/4885MAPK1 1240/4885 |
| US-12479849-B2 | EGFR inhibitors for the treatment of cancer | EGFR, ERBB2, ERBB3 | TSHR 217/4885CYP3A4 3802/4885MAPK1 728/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.